ACTA1 and cancer: One subset displays a matrix-synthesizing myofibroblastic phenotype termed myCAF, whereas another exhibits an immunomodulatory phenotype, inflammatory CAFs named iCAF [Figure 1] The CAFs proximal to the cancer cells show a myCAF phenotype with higher expression of α-SMA.